Eli Lilly and CompanyLLYNYSE
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 21.99% |
| Q3 2025 | 3.52% |
| Q2 2025 | 12.08% |
| Q1 2025 | 2.32% |
| Q4 2024 | 16.34% |
| Q3 2024 | -0.92% |
| Q2 2024 | 9.08% |
| Q1 2024 | 1.46% |
| Q4 2023 | 7.18% |
| Q3 2023 | -6.71% |
| Q2 2023 | 10.80% |
| Q1 2023 | 5.36% |
| Q4 2022 | 1.87% |
| Q3 2022 | -0.59% |
| Q2 2022 | 4.52% |
| Q1 2022 | -3.61% |
| Q4 2021 | 0.94% |
| Q3 2021 | -6.77% |
| Q2 2021 | 7.45% |
| Q1 2021 | 0.40% |
| Q4 2020 | 2.85% |
| Q3 2020 | 3.00% |
| Q2 2020 | -6.13% |
| Q1 2020 | -8.57% |
| Q4 2019 | 21.03% |
| Q3 2019 | -11.48% |
| Q2 2019 | 5.15% |
| Q1 2019 | -18.53% |
| Q4 2018 | 28.60% |
| Q3 2018 | -2.52% |
| Q2 2018 | 11.55% |
| Q1 2018 | -44.09% |
| Q4 2017 | 51.46% |
| Q3 2017 | -9.09% |
| Q2 2017 | 10.74% |
| Q1 2017 | -15.95% |
| Q4 2016 | 14.35% |
| Q3 2016 | -3.53% |
| Q2 2016 | 10.09% |
| Q1 2016 | -18.04% |